Braskem S.A. (NYSE:BAK - Get Free Report)'s stock price traded down 7.3% during trading on Friday . The company traded as low as $2.21 and last traded at $2.2350. Approximately 380,982 shares were traded during mid-day trading, a decline of 84% from the average session volume of 2,395,477 shares. The stock had previously closed at $2.41.
Analysts Set New Price Targets
BAK has been the subject of a number of analyst reports. Bradesco Corretora downgraded shares of Braskem from an "outperform" rating to an "underperform" rating and set a $1.50 target price for the company. in a research note on Tuesday, April 21st. JPMorgan Chase & Co. cut shares of Braskem from an "overweight" rating to a "neutral" rating in a research report on Tuesday, June 30th. Citigroup lowered Braskem from a "neutral" rating to a "sell" rating in a research report on Thursday, June 25th. Weiss Ratings reissued a "sell (e+)" rating on shares of Braskem in a research note on Friday, July 17th. Finally, Zacks Research lowered Braskem from a "strong-buy" rating to a "hold" rating in a research report on Monday, May 18th. Three analysts have rated the stock with a Hold rating and five have given a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Strong Sell" and an average price target of $3.40.
Get Our Latest Stock Report on BAK
Braskem Trading Down 3.9%
The company has a market cap of $922.77 million, a price-to-earnings ratio of -0.55, a P/E/G ratio of 0.13 and a beta of 1.61. The stock's 50-day moving average is $3.09 and its 200-day moving average is $3.61.
Braskem (NYSE:BAK - Get Free Report) last posted its quarterly earnings results on Thursday, May 14th. The company reported $0.69 earnings per share for the quarter, beating the consensus estimate of $0.21 by $0.48. The firm had revenue of $3.51 billion during the quarter, compared to the consensus estimate of $3.39 billion. Braskem had a negative net margin of 13.72% and a negative return on equity of 23.17%. As a group, analysts predict that Braskem S.A. will post 1.64 EPS for the current year.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently added to or reduced their stakes in BAK. UBS Group AG raised its position in shares of Braskem by 2.6% during the third quarter. UBS Group AG now owns 783,445 shares of the company's stock worth $1,896,000 after purchasing an additional 19,956 shares during the period. Brooklands Fund Management Ltd acquired a new stake in Braskem in the 1st quarter valued at $2,013,000. State Street Corp increased its stake in Braskem by 7.2% during the 4th quarter. State Street Corp now owns 311,507 shares of the company's stock valued at $919,000 after purchasing an additional 20,805 shares in the last quarter. Renaissance Technologies LLC increased its stake in Braskem by 619.5% during the 4th quarter. Renaissance Technologies LLC now owns 265,488 shares of the company's stock valued at $783,000 after purchasing an additional 228,588 shares in the last quarter. Finally, Jump Financial LLC raised its holdings in Braskem by 607.1% during the second quarter. Jump Financial LLC now owns 263,771 shares of the company's stock worth $865,000 after buying an additional 226,467 shares during the last quarter.
Braskem Company Profile
(
Get Free Report)
Braskem NYSE: BAK is a leading integrated petrochemical company based in São Paulo, Brazil, and holds the distinction of being the largest thermoplastic resins producer in Latin America. The company operates across the entire value chain, from feedstock sourcing and polymer production to distribution and recycling. Braskem's comprehensive approach to petrochemical manufacturing enables it to serve a diverse set of end markets with a broad portfolio of products.
Braskem's core product lines include polypropylene, polyethylene and polyvinyl chloride (PVC), which are used in industries such as packaging, automotive, construction and electrical & electronics.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Braskem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Braskem wasn't on the list.
While Braskem currently has a Strong Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.